marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-15-2023
CTI BioPharma Corp. Financial Ratios 2011-2024 | CTIC
Annual Financial Ratios CTI BioPharma Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.9 | -1.7 | -4.5 | -1.8 | -2.2 | -2.7 | -2.5 | -2.0 | -3.5 | -8.9 | -0.8 | -3.0 |
P/S |
10.2 | - | 56235.3 | 21.0 | 2.5 | 4.4 | 2.3 | 14.7 | 5.4 | 10.9 | - | - |
EPS |
-0.8 | -1.1 | -0.7 | -0.7 | -0.5 | -1.2 | -1.9 | -0.7 | -0.7 | -0.4 | -2.0 | -0.7 |
EV (Enterprise Value) |
664 M | 174 M | 214 M | 67.4 M | 66.1 M | 122 M | 142 M | 206 M | 310 M | 358 M | 75.2 M | 174 M |
EBITDA per Share |
-0.68 | -1.05 | -0.664 | -0.679 | -0.564 | -1.06 | -1.73 | -6.14 | -5.73 | -3.49 | -16.9 | -20.6 |
EV/EBITDA |
-1.0 | -4.3 | -1.2 | -1.4 | -2.5 | -2.2 | -1.4 | -3.2 | -8.1 | -0.4 | -2.0 | |
PEG |
4.94 | 0.95 | 0.62 | 0.05 | -0.04 | -0.08 | -0.03 | 0.94 | 0.07 | -0.11 | -0.02 | -0.06 |
P/B |
-31.3 | 45.5 | 5.9 | 3.9 | 1.2 | 6.8 | 16.7 | 5.0 | 8.5 | 8.9 | 2.6 | 6.7 |
P/CF |
-6.8 | -2.0 | -5.6 | -2.5 | -1.6 | -2.8 | -1.7 | -2.5 | -8.2 | -10.1 | -1.3 | -3.0 |
ROE % |
529.06 | -2599.10 | -131.03 | -223.20 | -55.38 | -252.77 | -670.48 | -251.88 | -242.65 | -99.96 | -307.72 | -222.64 |
ROA % |
-73.85 | -135.17 | -90.06 | -86.47 | -32.64 | -74.10 | -81.46 | -82.74 | -101.17 | -45.61 | -137.53 | -100.19 |
ROCE % |
453.99 | -2530.71 | -115.94 | -143.63 | -48.28 | -110.92 | -211.93 | -162.21 | -154.13 | -56.17 | -196.99 | -164.64 |
Current Ratio |
0.9 | 1.1 | 3.2 | 1.9 | 3.6 | 2.4 | 1.4 | 1.9 | 2.2 | 4.0 | 2.7 | 2.9 |
DSO |
52.1 | - | - | - | 189.9 | 18.6 | 51.9 | 6.4 | 12.2 | 2.5 | - | - |
DIO |
38.1 | - | - | - | - | 551.5 | 404.2 | 535.3 | 1705.5 | 13518.3 | - | - |
DPO |
306.4 | - | - | - | 1867.8 | 2595.1 | 1915.7 | 1991.3 | 2592.1 | 13457.0 | - | - |
Operating Cycle |
90.1 | - | - | - | 189.9 | 570.1 | 456.1 | 541.7 | 1717.7 | 13520.8 | - | - |
Cash Conversion Cycle |
-216.2 | - | - | - | -1677.9 | -2025.0 | -1459.6 | -1449.7 | -874.4 | 63.8 | - | - |
All numbers in USD currency
Quarterly Financial Ratios CTI BioPharma Corp.
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.1 | - | -0.13 | -0.21 | -0.37 | - | -0.26 | -0.21 | -0.23 | - | -0.15 | -0.19 | -0.2 | - | -0.17 | -0.19 | -0.19 | - | -0.26 | -0.2 | -0.08 | -0.33 | -0.28 | 0.03 | -0.71 | -0.23 | -1.04 | -0.71 | 0.12 | -0.13 | -0.19 | -0.19 | -0.16 | -0.27 | 0.03 | -0.19 | -0.2 | 0.08 | -0.2 | -0.17 | -0.18 | -0.2 | -0.38 | -1.38 | -0.43 | -0.47 | -0.8 | -0.14 | -0.35 |
EBITDA per Share |
-0.07 | - | -0.09 | -0.17 | -0.35 | - | -0.24 | -0.21 | -0.22 | - | -0.14 | -0.13 | -0.19 | - | -0.16 | -0.18 | -0.18 | - | -0.25 | -0.24 | -0.08 | - | -0.26 | 0.18 | -0.68 | - | -1 | -0.67 | 0.16 | - | -0.18 | -0.17 | -0.16 | - | 0.06 | -0.18 | -0.19 | - | -0.13 | -158 | -0.17 | -0.17 | -0.25 | -1.14 | -0.43 | -0.24 | -0.37 | -0.1 | -0.1 |
ROE % |
669.05 | 655.98 | 593.80 | 438.35 | -23.07 | -158.84 | -182.90 | -144.78 | -147.87 | -89.47 | -131.89 | -150.25 | -161.59 | -134.38 | -159.61 | -142.43 | -115.43 | -51.40 | -116.80 | -146.46 | -102.40 | -186.45 | -168.89 | -333.10 | -506.25 | -390.49 | -391.92 | -235.45 | -149.69 | -229.52 | -279.80 | -206.14 | -209.11 | -223.61 | -101.48 | -146.91 | -121.17 | -94.62 | -171.03 | -180.58 | -285.81 | -293.40 | -270.79 | -284.85 | -198.93 | -217.15 | -58.02 | -59.19 | -68.72 |
ROA % |
-54.23 | -57.84 | -81.73 | -92.89 | -101.44 | -89.63 | -108.96 | -104.42 | -103.07 | -64.30 | -86.01 | -88.38 | -88.05 | -68.78 | -85.27 | -80.04 | -68.96 | -33.58 | -59.57 | -64.90 | -42.45 | -74.10 | -58.09 | -81.98 | -122.78 | -81.46 | -89.26 | -66.15 | -57.80 | -82.82 | -110.08 | -82.49 | -89.58 | -101.17 | -45.25 | -66.82 | -56.35 | -45.61 | -81.72 | -85.74 | -134.54 | -137.53 | -126.70 | -132.86 | -92.16 | -100.19 | -26.77 | -27.31 | -31.71 |
ROCE % |
539.59 | 556.34 | 496.21 | 363.52 | -26.13 | -155.78 | -179.37 | -142.84 | -136.20 | -78.37 | -119.37 | -136.78 | -158.21 | -131.87 | -157.03 | -141.20 | -118.64 | -56.41 | -110.35 | -139.13 | -91.11 | -118.35 | -333.56 | -494.83 | -662.15 | -327.38 | -388.79 | -234.99 | -151.47 | -173.86 | -155.97 | -76.66 | -80.90 | -112.22 | -146.50 | -198.68 | -174.33 | -114.80 | -169.36 | -178.92 | -282.37 | -293.75 | -273.71 | -283.11 | -199.05 | -216.56 | -53.24 | -58.92 | -69.89 |
Current Ratio |
0.8 | 0.9 | 0.9 | 1.0 | 0.8 | 1.1 | 1.6 | 4.9 | 2.6 | 3.2 | 3.2 | 3.2 | 3.2 | 1.6 | 1.6 | 1.6 | 1.6 | 2.4 | 2.4 | 2.4 | 2.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | 1.1 | 1.5 | 1.5 | 1.5 | 1.5 | 1.8 | 1.8 | 1.8 | 1.8 | 2.5 | 2.5 | 2.5 | 2.5 | 2.7 | 2.7 | 2.7 | 2.7 | 3.0 | 3.0 | 3.0 | 3.0 |
DSO |
72.5 | - | 46.9 | 39.2 | 48.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.0 | 18.2 | 17.7 | 1.0 | 23.1 | 3.8 | 7.8 | 4.7 | 0.8 | 2.3 | 26.7 | 23.4 | 38.4 | 10.3 | 4.6 | 136.6 | 72.6 | 0.7 | 59.2 | 70.1 | 9.5 | - | - | - | - | - | - | - | - |
DIO |
56.3 | - | 73.2 | 40.0 | 16.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.8 | - | - | 761.1 | 643.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
150.3 | - | 219.4 | 274.8 | 1036.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | 3600.4 | 698.0 | - | - | 3422.5 | 3027.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
128.8 | - | 120.1 | 79.2 | 65.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.8 | 0.0 | 18.2 | 778.7 | 644.4 | 23.1 | 3.8 | 7.8 | 4.7 | 0.8 | 2.3 | 26.7 | 23.4 | 38.4 | 10.3 | 4.6 | 136.6 | 72.6 | 0.7 | 59.2 | 70.1 | 9.5 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-21.5 | - | -99.3 | -195.6 | -971.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | -3600.4 | -654.3 | 0.0 | 18.2 | -2643.8 | -2383.2 | 23.1 | 3.8 | 7.8 | 4.7 | 0.8 | 2.3 | 26.7 | 23.4 | 38.4 | 10.3 | 4.6 | 136.6 | 72.6 | 0.7 | 59.2 | 70.1 | 9.5 | - | - | - | - | - | - | - | - |
All numbers in USD currency